Nanox to Report Third Quarter and Financial Results on November 21, 2024
NNOX 11.11.2024
Date of Upcoming Event:2024-11-21
Name of Upcoming Event:Nanox Q3 Earnings Call
About Gravity Analytica
Recent News
- 12.05.2024 - Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
- 12.04.2024 - Opportunistic screening with AI could be a game-changer for preventive cardiology
- 12.04.2024 - Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey
Recent Filings
PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2024, before market open on Thursday, November 21, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link:Nanox Q3 Earnings Call Registration. You may access the live webcast of the conference call by using the following link:Nanox Q3 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website atEvents and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and novel digital source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for smarter diagnostics and maintaining a clinically-driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; Nanox.AI – an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages and stores data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance its better health outcomes worldwide. For more information, please visitwww.nanox.vision.
ContactsMedia Contact:Ben ShannonICR HealthcareNanoxPR@icrinc.comInvestor Contact:Mike CavanaughICR Healthcaremike.cavanaugh@westwicke.com